Allspring Global Investments Portfolio holdings
AUM
$59.8B
1-Year Return
21.41%
This Quarter Return
+7.92%
1 Year Return
+21.41%
3 Year Return
+84.27%
5 Year Return
–
10 Year Return
–
AUM
$60.2B
AUM Growth
+$1.83B
(+3.1%)
Cap. Flow
-$1.49B
Cap. Flow
% of AUM
-2.47%
Top 10 Holdings %
Top 10 Hldgs %
11.24%
Holding
3,015
New
117
Increased
1,166
Reduced
1,335
Closed
261
Top Buys
| 1 |
L3Harris
LHX
|
+$163M |
| 2 |
CubeSmart
CUBE
|
+$108M |
| 3 |
RBC Bearings
RBC
|
+$77.4M |
| 4 |
Uber
UBER
|
+$76.2M |
| 5 |
Fifth Third Bancorp
FITB
|
+$74.4M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$215M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$186M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$126M |
| 4 |
Amazon
AMZN
|
+$97.6M |
| 5 |
PayPal
PYPL
|
+$92.5M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Industrials | 13.23% |
| 3 | Healthcare | 11.98% |
| 4 | Financials | 11.8% |
| 5 | Consumer Discretionary | 11.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Navient
NAVI
$1.29B
| $136K | ﹤0.01% |
8,508
+3,521
| +71% | +$56.3K |
|
1927
Primis Financial Corp
FRST
$270M
| $136K | ﹤0.01% |
+14,100
| New | +$136K |
|
|
RXDX
1928
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $134K | ﹤0.01% |
1,250
-125
| -9% | -$13.4K |
|
1929
American Axle
AXL
$708M
| $134K | ﹤0.01% |
17,159
-843
| -5% | -$6.58K |
|
1930
Apogee Enterprises
APOG
$912M
| $133K | ﹤0.01% |
3,085
-215
| -7% | -$9.3K |
|
1931
ITT
ITT
$13.8B
| $132K | ﹤0.01% |
1,535
-36
| -2% | -$3.11K |
|
1932
Tarsus Pharmaceuticals
TARS
$2.08B
| $132K | ﹤0.01% |
10,532
-105
| -1% | -$1.32K |
|
1933
OneSpan
OSPN
$592M
| $132K | ﹤0.01% |
7,564
+3,118
| +70% | +$54.6K |
|
1934
Encore Capital Group
ECPG
$1.02B
| $132K | ﹤0.01% |
2,621
-946
| -27% | -$47.7K |
|
1935
Scorpio Tankers
STNG
$2.99B
| $132K | ﹤0.01% |
2,340
+493
| +27% | +$27.8K |
|
1936
Definitive Healthcare
DH
$432M
| $131K | ﹤0.01% |
12,695
-334
| -3% | -$3.45K |
|
1937
Atara Biotherapeutics
ATRA
$84.1M
| $131K | ﹤0.01% |
1,804
-24
| -1% | -$1.74K |
|
1938
Dycom Industries
DY
$7.51B
| $131K | ﹤0.01% |
1,396
-51,618
| -97% | -$4.83M |
|
1939
Amplitude
AMPL
$1.45B
| $131K | ﹤0.01% |
10,503
-106
| -1% | -$1.32K |
|
|
SUM
1940
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $130K | ﹤0.01% |
4,568
-620
| -12% | -$17.7K |
|
1941
Vaxcyte
PCVX
$4.2B
| $130K | ﹤0.01% |
3,469
-796
| -19% | -$29.8K |
|
1942
Conduent
CNDT
$447M
| $130K | ﹤0.01% |
37,829
-112
| -0.3% | -$384 |
|
1943
Ducommun
DCO
$1.39B
| $130K | ﹤0.01% |
2,370
+937
| +65% | +$51.3K |
|
1944
Thermon Group Holdings
THR
$861M
| $129K | ﹤0.01% |
5,189
-23,186
| -82% | -$578K |
|
1945
Denali Therapeutics
DNLI
$2.1B
| $129K | ﹤0.01% |
5,608
+2,366
| +73% | +$54.5K |
|
1946
Fulton Financial
FULT
$3.54B
| $128K | ﹤0.01% |
9,283
+1,827
| +25% | +$25.2K |
|
|
PRVB
1947
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $127K | ﹤0.01% |
5,290
+3,574
| +208% | +$86.1K |
|
1948
United Natural Foods
UNFI
$1.79B
| $127K | ﹤0.01% |
4,831
-4,464
| -48% | -$118K |
|
1949
Strategy Inc Common Stock Class A
MSTR
$93.7B
| $127K | ﹤0.01% |
4,350
+30
| +0.7% | +$877 |
|
1950
Emergent Biosolutions
EBS
$442M
| $127K | ﹤0.01% |
12,248
+6,660
| +119% | +$69K |
|